Mission statement · Company scope
“Our mission is to advance drug-free neuromodulation therapies that improve patient outcomes and reduce medication burden in complex disorders, while expanding access to effective care for populations with significant unmet needs.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Problem–solution (primary) · Democratization
- Leads with
- Problem
- Best for
- Climate & health · Service business
- Formula
- [Problem] shouldn’t [cost]. We [how].
- Tone
- Warm
- Length
- 31 words · reading grade 20.9
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_599675bf4ea0b490
- Classification confidence
- 0.67
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-19 · sec_sentence · 10-K · accession 0001493152-26-011505
View filing ↗0 to compareCompare